Depomed
(NASDAQ: DEPO)
-0.17
-2.81%
Depomed, a small-cap growth company in the health care sector, is expected to significantly outperform the market over the next six months with average risk.
10 is the best possible rating.
Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
Previous day's closing price for DEPO was slightly above its 50-day moving average. Positive
ConThe price-to-sales multiple is significantly higher than the average for all stocks in the StockScouter universe. Negative for a small company like DEPO
The most recent quarterly earnings report was significantly lower than analysts' consensus forecast. Negative
The most recent quarterly earnings report was significantly lower than analysts' consensus forecast. Negative
Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
One or more analysts has significantly increased quarterly earnings estimates for DEPO. Positive
Insider trading information is unavailable or inconsistent.
Shares are being heavily sold by financial institutions. Neutral for a small company like DEPO
The price-to-earnings multiple is a negative number. No effect
The price-to-sales multiple is significantly higher than the average for all stocks in the StockScouter universe. Negative for a small company like DEPO
The ratio of DEPO's price-to-earnings multiple to its five-year growth rate is unavailable or inconsistent.
The StockScouter measure of relative price change and consistency is flat. Neutral
Previous day's closing price for DEPO was slightly above its 50-day moving average. Positive
data provided by Verus Analytics
Learn more about the StockScouter rating system.
Page generated 6/19/2013 12:51 PM ET
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
